BDH-Klinik Greifswald, Greifswald, Germany.
Zentralklinik Bad Berka, Bad Berka, Germany.
Spinal Cord Ser Cases. 2023 Jul 29;9(1):37. doi: 10.1038/s41394-023-00597-z.
Structured patient feedback survey evaluating real-world home care use.
To assess the long-term effectiveness, tolerability, and satisfaction with the intermittent colonic exoperistalsis (ICE) treatment device MOWOOT in spinal cord-injured (SCI) individuals with chronic constipation.
Four specialized German hospitals.
SCI individuals with chronic constipation were invited to use MOWOOT 10-20 min daily and answer a questionnaire about their bowel situation before treatment (feedback 1, F1) and after ≥10 months of use (feedback 2, F2). Collected variables were device use, bowel function effectiveness, chronic constipation symptoms, concomitant use of laxatives and evacuation aids, and satisfaction with bowel function and management, which were compared between time points. At F2, participants reported efficacy, tolerability/side effects, and ease of use.
Eleven participants used the device for a mean (SD) of 13.27 (4.03) months. From F1 to F2, mean time per evacuation decreased by 24.5 min (p = 0.0076) and the number of failed attempts to evacuate/week, by 1.05 (p = 0.0354) with a tendency toward increased bowel movements and softer stool consistency, and decreased incomplete bowel movements. Participants experienced decreased difficulty/strain (p = 0.0055), abdominal pain (p = 0.0230), bloating (p = 0.0010), abdominal cramps (p = 0.0019), and spasms (p = 0.0198), without significant changes in the use of laxatives and evacuation aids. Satisfaction with bowel function and management improved (p = 0.0095) and more participants reported being very satisfied/satisfied (p = 0.0300). Most reported tolerability, efficacy, and ease of use as very good/good.
Long-term in-home ICE treatment improved bowel function and chronic constipation symptoms in SCI individuals, providing clinical benefits to this population.
SPONSORSHIP (MOWOOT DEVICES LENDING): 4 M Medical GmbH, Norderstedt, Germany.
评估真实世界家庭护理使用情况的结构化患者反馈调查。
评估间歇性结肠外蠕动(ICE)治疗装置 MOWOOT 在慢性便秘的脊髓损伤(SCI)个体中的长期有效性、耐受性和满意度。
四家德国专业医院。
慢性便秘的 SCI 个体被邀请每天使用 MOWOOT 10-20 分钟,并在治疗前(反馈 1,F1)和使用≥10 个月后(反馈 2,F2)回答关于其肠道情况的问卷。收集的变量包括设备使用、肠道功能效果、慢性便秘症状、泻药和排便辅助工具的同时使用,以及对肠道功能和管理的满意度,这些变量在时间点之间进行了比较。在 F2,参与者报告了疗效、耐受性/副作用和易用性。
11 名参与者平均(SD)使用该设备 13.27(4.03)个月。从 F1 到 F2,每次排便的平均时间减少了 24.5 分钟(p=0.0076),每周失败的排便尝试次数减少了 1.05 次(p=0.0354),排便次数增加,粪便变软,不完全排便减少。参与者的排便困难/紧张感(p=0.0055)、腹痛(p=0.0230)、腹胀(p=0.0010)、腹部痉挛(p=0.0019)和痉挛(p=0.0198)减轻,而泻药和排便辅助工具的使用没有明显变化。对肠道功能和管理的满意度提高(p=0.0095),更多的参与者报告非常满意/满意(p=0.0300)。大多数人报告说耐受性、疗效和易用性非常好/好。
长期家庭 ICE 治疗改善了 SCI 个体的肠道功能和慢性便秘症状,为该人群提供了临床益处。
(MOWOOT 设备出借)赞助:4M Medical GmbH,Norderstedt,德国。